Freestone Capital Holdings’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $480K | Sell |
|
|||||
|
2025
Q2 | $902K | Buy |
|
|||||
|
2025
Q1 | $953K | Sell |
|
|||||
|
2024
Q4 | $2.71M | Sell |
|
|||||
|
2024
Q3 | $4.08M | Buy |
|
|||||
|
2024
Q2 | $1.96M | Sell |
|
|||||
|
2024
Q1 | $3.07M | Sell |
|
|||||
|
2023
Q4 | $3.15M | Sell |
|
|||||
|
2023
Q3 | $3.86M | Buy |
|
|||||
|
2023
Q2 | $4.11M | Buy |
|
|||||
|
2023
Q1 | $4.44M | Sell |
|
|||||
|
2022
Q4 | $4.81M | Sell |
|
|||||
|
2022
Q3 | $5.97M | Sell |
|
|||||
|
2022
Q2 | $7.79M | Sell |
|
|||||
|
2022
Q1 | $8.78M | Sell |
|
|||||
|
2021
Q4 | $7.61M | Buy |
|
|||||
|
2021
Q3 | $7.13M | Buy |
|
|||||
|
2021
Q2 | $7.95M | Sell |
|
|||||
|
2021
Q1 | $9.09M | Sell |
|
|||||
|
2020
Q4 | $9.05M | Buy |
|
|||||
|
2020
Q3 | $7.75M | Buy |
|
|||||
|
2020
Q2 | $7.53K | Buy |
|
|||||
|
2020
Q1 | $6.68K | Sell |
|
|||||
|
2019
Q4 | $8.02K | Sell |
|
|||||
|
2019
Q3 | $7.19K | Buy |
|
|||||
|
2019
Q2 | $4.98K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $212K | Sell |
|
|||||
|
2017
Q3 | $236K | Buy |
|